
|Articles|July 13, 2012
Why Big Pharma Won't Get Its Piece Of The $1.2 Trillion Global Drug Market
Advertisement
The global market for prescription drugs will grow from $950 billion now to $1.2 trillion in 2016, according to a new report released today. But Big Pharma may sit out much of the growth as patents on big-selling drugs expire and people fast-growing markets such as China, Russia, and Brazil buy generic drugs from local manufacturers.
Read the full story:
Source: Forbes
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Chemoradiotherapy Improved Survival in Older Patients With Stage 2 NSCLC
2
Single-Tablet Bictegravir/Lenacapavir Effective After Treatment Switch
3
Non-Invasive Tests Show Promise for Tracking Treatment Response in Semaglutide MASH Trial
4
Flow Cytometry Tracks CAR T-Cell Therapy Persistence in Aggressive LBCL
5














































